Application of Herbal Traditional Chinese Medicine in the Treatment of Lupus Nephritis

Overview

Journal Front Pharmacol

Date 2022 Dec 12

PMID 36506523

Authors

Liu Liu

Lei Zhang

Ming Li

Affiliations

Soon will be listed here.

Abstract

Lupus nephritis (LN) is a secondary renal disease caused by systemic lupus erythematosus affecting the kidneys. It is one of the main causes of end-stage renal disease and a serious risk factor for early mortality and disability of systemic lupus erythematosus patients. Existing LN treatment is mainly based on hormones, cytotoxic drugs, and biological agents. Nevertheless, the prognosis of LN patients remains poor because of frequent recurrence and exacerbation of adverse drug reactions. Hence, LN is still the most important cause of end-stage renal disease. In recent years, traditional Chinese medicine (TCM) has attracted increasing attention because of encouraging evidence that it alleviates LN and the well-described mechanisms underlying renal injury. TCM has therapeutic benefits for treating LN patients. This review article elucidates TCM preparations, TCM monomers, and herbal or natural extraction for LN treatment to provide effective supplementary evidence for promoting the development of TCM treatment for LN and reference for future research and clinical practice.

Citing Articles

Astragalus-containing Chinese herbal medicine used with Western medicine for lupus nephritis: a systematic review and meta-analysis of randomized controlled trials.

Li J, Wu M, Liu W Front Pharmacol. 2025; 15:1395844.

PMID: 40061256 PMC: 11885490. DOI: 10.3389/fphar.2024.1395844.

Network pharmacology to unveil the mechanism of Astragali Radix in the treatment of lupus nephritis via PI3K/AKT/mTOR pathway.

Zhan K, Chen S, Ji L, Xu L, Zhang Y, Zhang Q Sci Rep. 2024; 14(1):25983.

PMID: 39472740 PMC: 11522298. DOI: 10.1038/s41598-024-77897-3.

Ferroptosis and secondary nephrosis.

Zhang Y, Yang L Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 49(3):377-384.

PMID: 38970511 PMC: 11208398. DOI: 10.11817/j.issn.1672-7347.2024.230377.

Renal and survival benefits of seventeen prescribed Chinese herbal medicines against oxidative-inflammatory stress in systemic lupus erythematosus patients with chronic kidney disease: a real-world longitudinal study.

Chen H, Tung C, Yu B, Chang C, Chen Y Front Pharmacol. 2024; 14:1309582.

PMID: 38235107 PMC: 10791791. DOI: 10.3389/fphar.2023.1309582.

References

Tan Y, Chen H, Li J, Wu Q . Efficacy, Chemical Constituents, and Pharmacological Actions of and . Front Pharmacol. 2020; 11:1054. PMC: 7365904. DOI: 10.3389/fphar.2020.01054. View

Mahajan A, Amelio J, Gairy K, Kaur G, Levy R, Roth D . Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus. 2020; 29(9):1011-1020. PMC: 7425376. DOI: 10.1177/0961203320932219. View

Choi T, Jun J, Lee M . Integrative medicine for managing the symptoms of lupus nephritis: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2018; 97(13):e0224. PMC: 5895401. DOI: 10.1097/MD.0000000000010224. View

Liu Y, He H, Ding Y, Wu S, Chen D, E C . [Effects of Triptolide on Tc and Th Cell Excursion in Peripheral Blood of Nude Mice with Systemic Lupus Erythematosus BALB/c-un]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019; 27(5):1691-1695. DOI: 10.19746/j.cnki.issn.1009-2137.2019.05.051. View

Drehmer M, Andrade D, Pereira I, Marrero A, Muniz Y, de Souza I . Estrogen receptor alpha gene ( ESR1) polymorphism can contribute to clinical findings in systemic lupus erythematosus patients. Lupus. 2016; 26(3):294-298. DOI: 10.1177/0961203316668041. View

Chang C, Wu P, Chiang J, Wei Y, Chen F, Chen T . Integrative therapy decreases the risk of lupus nephritis in patients with systemic lupus erythematosus: A population-based retrospective cohort study. J Ethnopharmacol. 2016; 196:201-212. DOI: 10.1016/j.jep.2016.12.016. View

Lesiak A, Narbutt J, Sysa-Jedrzejowska A, Lukamowicz J, McCauliffe D, Wozniacka A . Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus. Lupus. 2010; 19(6):683-8. DOI: 10.1177/0961203309356455. View

Hou X, Xu M, Li J, Li R, Zhang J, Ju J . Study of the Therapeutic Effects of Chinese Herbal Decoction Combined with Glucocorticoid in Treating Primary Nephrotic Syndrome in Children. Evid Based Complement Alternat Med. 2021; 2021:4434504. PMC: 8626201. DOI: 10.1155/2021/4434504. View

Li C, Pan J, Xu C, Jin Z, Chen X . A Preliminary Inquiry Into the Potential Mechanism of Huang-Lian-Jie-Du Decoction in Treating Rheumatoid Arthritis Network Pharmacology and Molecular Docking. Front Cell Dev Biol. 2022; 9:740266. PMC: 8807552. DOI: 10.3389/fcell.2021.740266. View

10.

Liu M, Dong R, Hua Z, Lv N, Ma Y, Huang G . Therapeutic potential of Liuwei Dihuang pill against KDM7A and Wnt/β-catenin signaling pathway in diabetic nephropathy-related osteoporosis. Biosci Rep. 2020; 40(9). PMC: 7502694. DOI: 10.1042/BSR20201778. View

11.

Cheng X, Qi C, Wang T, Zhou W, Zhang Y . Characteristics of the traditional Liu-Wei-Di-Huang prescription reassessed in modern pharmacology. Chin J Nat Med. 2019; 17(2):103-121. DOI: 10.1016/S1875-5364(19)30013-5. View

12.

Furuya Y, Kawakita T, Nomoto K . Immunomodulating effect of a traditional Japanese medicine, hachimi-jio-gan (ba-wei-di-huang-wan), on Th1 predominance in autoimmune MRL/MP-lpr/lpr mice. Int Immunopharmacol. 2001; 1(3):551-9. DOI: 10.1016/s1567-5769(00)00024-2. View

13.

Balkrishna A, Thakur P, Singh S, Chandra Dev S, Varshney A . Mechanistic Paradigms of Natural Plant Metabolites as Remedial Candidates for Systemic Lupus Erythromatosus. Cells. 2020; 9(4). PMC: 7226400. DOI: 10.3390/cells9041049. View

14.

Song C, Xu Y, Lu Y . Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects. J Zhejiang Univ Sci B. 2020; 21(4):280-290. PMC: 7183448. DOI: 10.1631/jzus.B1900607. View

15.

Wang W, Cao L, Wang X, Fan Y . Radix Paeoniae Rubra Ameliorates Lupus Nephritis in Lupus-Like Symptoms of Mrl Mice by Reducing Intercellular Cell Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, and Platelet Endothelial Cell Adhesion Molecule-1 Expression. Comb Chem High Throughput Screen. 2020; 23(7):675-683. DOI: 10.2174/1386207323666200517114802. View

16.

Jiang H, Li J, Wang L, Wang S, Nie X, Chen Y . Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action. J Ethnopharmacol. 2020; 258:112913. DOI: 10.1016/j.jep.2020.112913. View

17.

Hongqin T, Xinyu L, Heng G, Lanfang X, Yongfang W, Shasha S . Triptolide inhibits IFN-γ signaling via the Jak/STAT pathway in HaCaT keratinocytes. Phytother Res. 2011; 25(11):1678-85. DOI: 10.1002/ptr.3471. View

18.

Yingyan Z, Huasheng L, Jingyao Y, Xiaohong H, Lili P, Xue L . Effectiveness and safety of tripterygium glycosides tablet for lupus nephritis: a systematic review and Meta-analysis. J Tradit Chin Med. 2022; 42(5):671-680. PMC: 9924789. DOI: 10.19852/j.cnki.jtcm.2022.05.001. View

19.

Wu Y, He S, Bai B, Zhang L, Xue L, Lin Z . Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation. Cell Mol Immunol. 2015; 13(3):379-90. PMC: 4856803. DOI: 10.1038/cmi.2015.13. View

20.

Fanouriakis A, Kostopoulou M, Cheema K, Anders H, Aringer M, Bajema I . 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis. 2020; 79(6):713-723. DOI: 10.1136/annrheumdis-2020-216924. View